The purpose of this study is to: a) evaluate the effectiveness of ondansetron (Zofran) in the
treatment of alcohol dependent patients; b) investigate whether early versus late onset
alcoholism predicts treatment outcome; and c) determine whether the early and late onset
groups respond differently to treatment. Individuals will be "typed" into early onset and
late onset alcoholism groups. Individuals will be randomly assigned to a 12-week outpatient
treatment program.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)